#United States #Nashville #Thyme Care #Dr. Brad Diephuis #Robin Shah

Thyme Care Leadership Changes: A New Strategic Direction

On July 15, 2026, Thyme Care, a renowned company in the oncology sector, made headlines with a major leadership shift. Dr. Brad Diephuis has been appointed as the new Chief Executive Officer, while co-founder Robin Shah transitions to the role of Executive Chairman. This strategic move aims to expand Thyme Care's reach and enhance its commitment to improving patient care in oncology.

New Leadership Structure

Thyme Care’s core mission revolves around aligning accountability across the entire cancer care journey. Under the guidance of its newly appointed leaders, the company is set to bolster its operations, focusing on new business lines centered on drug affordability, clinical trial access, and improved care alignment. Shah will dedicate his efforts to these new initiatives while continuing to oversee the existing successful operations that Thyme Care has built over the past six years.

Dr. Brad Diephuis steps into the CEO role from his previous position as President and Chief Operating Officer. He brings extensive experience that combines clinical care, healthcare operations, and business strategy, making him well-suited to lead the company into its next phase. Diephuis, a cancer survivor himself, has been integral to Thyme Care's recent growth and payer expansion strategies since joining the company in 2022. His firsthand experience adds a profound understanding of the patient experience, which is invaluable to leading the organization.

Vision for the Future

Diephuis expressed a commitment to enhancing the overall patient experience by ensuring that healthcare providers and plans can work cohesively. He remarked, “For too long, the responsibility for what happens in cancer care has been spread across so many parties that no one is connecting the dots for the person living through it. Thyme Care was built to put the patient at the center.” His vision emphasizes the importance of teamwork in healthcare, where patients feel supported and providers have reliable partners.

In conjunction with Diephuis’s promotion, Thyme Care has welcomed Marcia Macphearson as the Chief Operating Officer. Macphearson comes with 25 years of experience in healthcare, having previously worked as Chief Commercial Officer at Imagine Pediatrics. Her background in scaling value-based care business aligns well with Thyme Care’s focus on enhancing patient outcomes through coordinated care.

Commercial Momentum and Growth Opportunities

Despite the transition in leadership, Thyme Care continues to see significant commercial progress. In the first half of 2026, the company successfully added three new health plan partners, solidifying relationships with national Medicare Advantage and commercial health plans. Thyme Care’s annual Impact Report indicates that the organization has achieved notable reductions in inpatient utilization and costs for their members, a testament to the efficacy of its operational model.

With the foundational model successfully scaled, Thyme Care is eyeing larger challenges within oncology care. The focus will include tackling issues such as drug price volatility, expanding access to clinical trials, and ensuring seamless care alignment across various stakeholders. Shah’s strategic vision involves utilizing Thyme Care's established infrastructure and data capabilities to bridge gaps that have persisted between patients, providers, and payers.

Conclusion

Thyme Care's leadership realignment marks a pivotal moment in the company's evolution. As it embraces a broader vision for oncology, the combined expertise of Diephuis, Shah, and Macphearson is expected to drive innovation and enhance the quality of care for cancer patients nationwide. Thyme Care is poised to redefine the oncology landscape by focusing on collaborative approaches that connect patients with quality care providers and insurance plans, ensuring no patient is left unsupported throughout their cancer journey.

To learn more about Thyme Care and its initiatives, visit thymecare.com.